DrHeba

‫ﻣﺠﻠﺔ اﻟﻌﻠﻮم و اﻟﻤﻌﺮﻓﺔ ﻟﻠﺠﻤﯿﻊ‬ ‫6002 ‪August - September‬‬ ‫ﺣـﻀـﺎرة اﻟﻤـﺎﯾـﺎ‬ ‫ﺑﺎﻹﺿـﺎﻓﺔ اﻟﻰ:‬ ‫وﺻـﻔـﺎت اﻟﺠـﺪة‬ ‫ﻣـﻦ ﺟـﺎء أوﻻ ً؟‬ ‫ﻋﺠـﺎﺋﺐ‬ ‫اﻟﺪﻧﯿﺎ اﻟﺴـﺒﻊ‬ ‫ﻣـﺎ ھﻲ‬ ‫اﻟﻌـﻠﻮم؟‬ ‫‪PROSPECTS‬‬ ‫‪OF SCIENCE‬‬ ‫ﻣﺤﺘﻮﯾﺎت اﻟﻌـﺪد‬ ‫آﻓﺎق اﻟﻌـﻠﻢ – اﻟﻌـﺪد رﻗﻢ 01‬ ‫أﺧﺒﺎر ﻋﻠﻤﯿﺔ‬ ‫ﺳـﺆ

CHAPTER 1 Introduction Author: Michael Makoid and John Cobby Reviewer: Phillip Vuchetich OBJECTIVES At the completion of this chapter, the successful student shall be able to: 1. 2. 3. 4. 5. 6. 7. 8. define pharmacokinetics state the overall objectives of the course state the major themes of the course state the course organizational structure with respect to study sections state the objecti...

`PHARMACOKINETICS: MAMMILLARY MODELS For many drugs, the equilibrium between drug concentrations in different tissues is not achieved rapidly. Thus, one of the assumptions of the one-compartment open model sometimes becomes invalid. A more complex mammillary open model is often necessary to describe mathematically the plasma concentration data (for example) seen after the administration of some...

CHAPTER 7 Oral Dosing Author: Michael Makoid and John Cobby Reviewer: Phillip Vuchetich OBJECTIVES After successfully completing this chapter, the student shall be able to 1. Given patient drug concentration and/or amount vs. Time profiles, the student will calculate (III) the relevant pharmacokinetic parameters ( V d , K, k m , k r , k a , AUC , Clearance, MRT, MAT) available from oral data...

:: Tolbutamide (Problem 1) Miners J, Foenander T, Wanwimolruk S, Gallus A, Birkett D. (European Journal of Clinical Pharmacology) The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination (1982) 22: 321-326. About the drug: Tolbutamide is a sulfonylurea which has been used as an oral hypoglycemic agent in noninsulin-dependent Diabetes Miletus w...

CHAPTER 16 Exam 3 Author: Reviewer: Basic Pharmacokinetics Copyright © 1996-1999 Michael C. Makoid All Rights Reserved REV. 99.4.25 http://kiwi.creighton.edu/pkinbook/ 16-1 Exam 3 16.1 Pharmacokinetics Final Exam Summer 1996 Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) with antidepressant properties. After oral administration, the drug is almost completely absorbed fr...

CHAPTER 15 Practice Exams: Exam 2 Basic Pharmacokinetics Copyright © 1996-1999 Michael C. Makoid All Rights Reserved REV. 99.4.25 http://kiwi.creighton.edu/pkinbook/ 15-1 Practice Exams: Exam 2 15.1 Nifedipine: Exam 2 Nifedipine (Procardia @) is a calcium channel blocker which specifically inhibits potential-dependent channels not receptor-operated channels, preventing calcium influx of ...

CHAPTER 14 Practice Exams: Section 1 Author: Michael Makoid Reviewer: Vicki Long ORGANIZATION Following are several exams which have been used in previous classes. These exams cover Chapters 1 through 4. Answers (including the graphs) are included in a format similar to real exam conditions, and some exams have the problems worked out completely. You are encouraged to work out the exams unde...

Non-Linear Pharmacokinetics Non-linear pharmacokinetic models, as opposed to linear pharmacokinetic models differ in some very critical areas. When the concentration that results from the dose is proportional to that dose and the rate of elimination of the drug is proportional to the concentration, the drug is said to exhibit linear pharmacokinetics as shown below. Figure 13-1-1 30 25 100 Figu...

CHAPTER 12 Protein Binding Author: Michael Makoid Reviewer: Phillip Vuchetich OBJECTIVES 2. Basic Pharmacokinetics Copyright © 1996-1999 Michael C. Makoid All Rights Reserved REV. 99.4.25 http://kiwi.creighton.edu/pkinbook/ 12-1